December 2011 Heart Health

Whether obtained through diet or supplements, omega-3 fatty acids provide many benefits to cardiovascular health.

Helping patients understand and identify anemia's underlying cause can promote adherence to treatment.

Bonny Chan seeks to improve public health one patient at a time.

As more fixed-dose combination products receive approval, pharmacists should familiarize themselves with these drugs' advantages and disadvantages.

A pharmacist who lost his licence after destroying inventory argues that his due process rights were violated.

In the past, the most effective pain drugs were the most commonly diverted, but this trend may be changing.

A successful treatment strategy for angina requires an understanding of an individual patient's symptoms and history.

The winner of our first annual essay contest, Jay Sochoka, BSPharm, RPh, CIP, shares his story of rediscovering the impact of pharmacy practice.

The success--and challenges--of Medicare Part D's Medication Therapy Management Programs can inform the future of this collaborative practice.

The FDA approved Xarelto (rivaroxaban) for the prevention of venous thromboembolism following hip or knee replacements and for the prevention of stroke in patients with nonvalvular atrial fibrillation.

Pharmacists should be familiar with drugs that impact the activity of the enzyme cytochrome P450 2C8.

Look-alike, sound-alike drug errors are easily preventable with the proper intervention.

Is a low-molecular-weight heparin program right for your pharmacy?

The rapid heartbeat and other symptoms of supraventricular tachycardia can be extremely alarming, but the condition is typically not life-threatening

Patients with cardiovascular risks can take a proactive approach to their health by starting a low-dose aspirin regimen.